MassBank MassBank Search Contents Download

MassBank Record: KO002713

2-Deoxystreptamine; LC-ESI-QQ; MS2; CE:30 V; [M+H]+

Mass Spectrum
Chemical Structure
Generated by the Chemistry Development Kit (http://github.com/cdk)

ACCESSION: KO002713
RECORD_TITLE: 2-Deoxystreptamine; LC-ESI-QQ; MS2; CE:30 V; [M+H]+
DATE: 2016.01.19 (Created 2007.07.07, modified 2011.05.10)
AUTHORS: Kakazu Y, Horai H, Institute for Advanced Biosciences, Keio Univ.
LICENSE: CC BY-NC-SA
COMMENT: KEIO_ID D061

CH$NAME: 2-Deoxystreptamine
CH$COMPOUND_CLASS: N/A
CH$FORMULA: C6H14N2O3
CH$EXACT_MASS: 162.10044
CH$SMILES: N[C@H](C1)[C@H](O)[C@@H](O)[C@H](O)[C@@H](N)1
CH$IUPAC: InChI=1S/C6H14N2O3/c7-2-1-3(8)5(10)6(11)4(2)9/h2-6,9-11H,1,7-8H2/t2-,3+,4+,5-,6-
CH$LINK: CAS 2037-48-1
CH$LINK: KEGG C02627
CH$LINK: PUBCHEM SID:5608
CH$LINK: INCHIKEY DTFAJAKTSMLKAT-JDCCYXBGSA-N

AC$INSTRUMENT: API3000, Applied Biosystems
AC$INSTRUMENT_TYPE: LC-ESI-QQ
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 30 V

MS$FOCUSED_ION: PRECURSOR_M/Z 163
MS$FOCUSED_ION: PRECURSOR_TYPE [M+H]+

PK$SPLASH: splash10-004j-0900000000-43c73aaab22efea3299c
PK$NUM_PEAK: 35
PK$PEAK: m/z int. rel.int.
  56.300 59406.0 1
  56.900 49505.0 1
  57.200 69307.0 2
  60.100 64356.5 1
  61.700 14851.5 1
  67.100 74257.5 2
  67.900 574258.0 13
  69.000 94059.5 2
  72.200 79208.0 2
  74.000 34653.5 1
  74.300 19802.0 1
  77.200 69307.0 2
  80.200 44554.5 1
  82.100 227723.0 5
  84.300 772278.0 17
  85.300 297030.0 7
  88.600 29703.0 1
  91.200 153465.5 3
  91.900 118812.0 3
  95.000 19802.0 1
  99.800 29703.0 1
  101.200 668317.5 15
  102.200 346535.0 8
  106.100 34653.5 1
  109.000 59406.0 1
  110.400 826733.5 18
  114.200 193069.5 4
  117.200 118812.0 3
  118.400 74257.5 2
  127.100 84158.5 2
  128.100 44703015.0 999
  130.400 64356.5 1
  131.800 39604.0 1
  146.000 39306970.0 878
  162.900 69307.0 2
//

Imprint Feedback
system version 2.1.8
Copyright © 2006 MassBank Project; 2011 NORMAN Association; 2021 MassBank Consortium
Responsible: Dr. Tobias Schulze